AA
Anthony E Altig
Director

Anthony E Altig insider trades: Optimer Pharmaceuticals (OPTR) stock buys and sales

Director, Optimer Pharmaceuticals Last trade Aug 9, 2011 63 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2006
7
Companies
last trade 2011

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Anthony reports to the SEC

and 1 more company

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 9, 2011OPTR↑ Buy$37K
Jun 30, 2011TEAR↑ Buy$50K
Mar 2, 2007DVSA↓ Sell$8K
Feb 23, 2007DVSA↓ Sell10b5-1$13K
Feb 16, 2007DVSA↓ Sell10b5-1$72K
Feb 24, 2006DVSA↓ Sell$4K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Anthony E Altig's insider trades

Anthony E Altig is a director at Optimer Pharmaceuticals (OPTR). Since Feb 24, 2006, Anthony has reported 2 open-market purchases worth $87K and 4 sales worth $96K on SEC Form 4. There have been no open-market trades in the last 12 months.

2 sales (88% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (52 filings), other transactions (3 filings), shares returned to the company (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.